Paul Breillat/LinkedIn
Jul 8, 2026, 19:25
Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article by Holly Webster, published in Nature Reviews Rheumatology, adding:
“Happy to see that our latest article on monocyte dysfunction and inflammatory cell death in VEXAS syndrome has been highlighted by Nature Reviews Rheumatology!
Many thanks to all the collaborators and co-authors who made this work possible.”
Title: Dysfunctional UBA1-mutated myeloid cells promote inflammation in VEXAS syndrome
Authors: Holly Webster
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target